Katie Loi
Parkville, NSW 3010, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Exploration and Characterization of the Antimalarial Activity of Pyrimidine-2,4-Diamines for which Resistance is Mediated by the ABCI3 Transporter.
Journal: ChemMedChem
Published: August 29, 2025
Optimization and Characterization of the Antimalarial Activity of N-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1.
Journal: Journal of medicinal chemistry
Published: July 18, 2025
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4.
Journal: Journal of medicinal chemistry
Published: April 14, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b.
Journal: European journal of medicinal chemistry
Published: September 03, 2024
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4.
Journal: Journal of medicinal chemistry
Published: August 12, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3.
Journal: European journal of medicinal chemistry
Published: June 13, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 protein.
Journal: European journal of medicinal chemistry
Published: January 30, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026